相关实验视频

Updated: Jun 9, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

电流重编程优化KRAS特异化疗诱导胰腺癌抗瘤免疫力

Qinglian Hu¹, Jiayu Feng¹, Lulu Qi¹

¹College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.

ACS applied materials & interfaces

|October 31, 2024

概括

这项研究引入了一种新的策略,通过重编程瘤微环境来治疗胰腺癌. 药物的顺序递送有效地抑制瘤生长并增强抗瘤免疫力,为感冒瘤提供了一个有希望的方法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

胰腺管道腺癌 (PDAC) 是一种具有挑战性的癌症,具有密集的肌层和KRAS突变,有助于免疫抑制瘤微环境 (TME).
将免疫学上"冷"的PDAC转换为"热"对于改善治疗结果至关重要.

研究的目的:

开发一种可编程的策略来治疗PDAC,通过通过脂质体顺序输送皮尔费尼 (PFD),KRAS抑制剂 (AMG510) 和凝素 (GEM).
研究该策略在重编程TME,增强药物输送和刺激抗瘤免疫力方面的潜力.

主要方法:

顺序递送PFD以通过重新编程胰腺恒星细胞 (PSCs) 来减少细胞外基质 (ECM).
随后提供纳米工程 KRAS 抑制剂 (AMG510) 和 gemcitabine (GEM) 脂质体以抑制瘤增殖和促进免疫细胞死亡 (ICD).
在PDAC的临床前小鼠模型中进行评估,以评估瘤生长抑制,纳米粒子透和免疫反应.

主要成果:

通过PFD介导的 stromal调制增强了纳米粒子透和改善了瘤生长抑制.
综合策略有效抑制了瘤的扩散和迁移,对化疗敏感,并促进了ICD.
分子机制揭示了肌瘤干预和KRAS通路调节重塑了PDAC免疫抑制,优化了细胞毒性T细胞介导免疫力.

结论:

这种顺序性药物输送策略提供了一种实用的方法来治疗免疫冷PDAC.
这种方法增强了抗瘤免疫力,并提供了持续的抗瘤记忆力.
这项研究对PDAC治疗具有显著的临床翻译前景.

关键词:

在KRAS信号通道上.细胞外矩阵是细胞外矩阵.免疫性细胞死亡免疫性细胞死亡纳米工程制造的脂质体胰腺癌的治疗方法

更多相关视频

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

Published on: June 8, 2018

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...